← Open Payments lookup

AMY CALICE: Open Payments

NPI 1033605183 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,392 in 74 payments from 22 companies in 2025. Trend: 2023 $2,189 · 2024 $1,827 · 2025 $1,392

Food & beverage: $1,392
CompanyPaymentsAmount
ABBVIE INC.33$596
AstraZeneca Pharmaceuticals LP3$138
Lilly USA, LLC5$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$67
Sumitomo Pharma America, Inc.3$66
Boehringer Ingelheim Pharmaceuticals, Inc.4$64
Novo Nordisk Inc3$47
Astellas Pharma US Inc2$38
Otsuka America Pharmaceutical, Inc.2$36
Dexcom, Inc.2$35

Products named: VRAYLAR, QULIPTA, FARXIGA, UBRELVY, MOUNJARO, CAPLYTA, GEMTESA, JARDIANCE.

Industry payments across MO — which companies pay providers there.